Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth - Wikidata - awgldk - TriplyDB

Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth

Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth

http://www.wikidata.org/entity/Q37202183

about

Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice.PPARs and the cardiovascular system The biological actions of dehydroepiandrosterone involves multiple receptors Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation.PPARs: Protectors or Opponents of Myocardial Function?Mitochondrial dysfunction in heart failure Using exercise to measure and modify cardiac function Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs Upstream stimulatory factor represses the induction of carnitine palmitoyltransferase-Ibeta expression by PGC-1 Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4 A PPARα promoter variant impairs ERR-dependent transactivation and decreases mortality after acute coronary ischemia in patients with diabetes Effects and mechanisms of PPARalpha activator fenofibrate on myocardial remodelling in hypertension.Association and interaction of PPAR-complex gene variants with latent traits of left ventricular diastolic function Circadian rhythms and metabolic syndrome: from experimental genetics to human disease.What we know and do not know about sex and cardiac disease.Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice.Linoleate-rich high-fat diet decreases mortality in hypertensive heart failure rats compared with lard and low-fat diets Molecular determinants of the cardiometabolic phenotype.Prenatal Hypoxia Reduces Mitochondrial Protein Levels and Cytochrome c Oxidase Activity in Offspring Guinea Pig Hearts The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic Disease.Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol MEK1 inhibits cardiac PPARα activity by direct interaction and prevents its nuclear localization.Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction.Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride.Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target.Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach.Mitochondrial proteins in hypertrophy and atrophy: a transcript analysis in rat heart.Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity.Deficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha.Glucose metabolism and cardiac hypertrophy Enhanced nanomagnetic gene transfection of human prenatal cardiac progenitor cells and adult cardiomyocytes.Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy.Ras/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI.PPAR-alpha effects on the heart and other vascular tissues.Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia.

P2860

Q24541529-244F477D-1BCC-45B8-A98F-25E27D9DCD2B Q24561461-AEBE84A6-F1D2-46E8-95E4-7B6EA8B5A5C7 Q24598637-46DBC40C-AF9A-4253-ABAA-FC3E2245D40E Q24642728-6B583253-618B-47D0-9385-B8E710EE5884 Q24657968-E6422179-858F-463B-BE20-D7F5C2D47234 Q24806958-176DFEAD-FBA5-41E2-9442-B5C8019E8E4A Q26771753-BB4B872D-20F3-4B4F-9908-9F5F898270C4 Q26851293-5AC93629-B1B9-4476-8BCE-072368933009 Q26994995-DC6C4A96-BB1B-4EB0-9EBD-A1414B39D55C Q28188766-6FD47F01-EF6C-4F9B-B916-16CC43F3A37A Q28213001-E2901CBC-83B6-4123-AC74-00167158A724 Q28366335-0FB0E7DD-C595-476C-8AF6-83B1B4EFFF5E Q28570494-4CC0D578-EC7D-4A77-AEE1-AF3E5B829C41 Q28574163-5D19428D-043B-47B8-8403-2EFCC0B90F02 Q28749469-4FEB070B-62FA-4619-ADC6-FE23B9329EA2 Q30406299-9E22B77E-5C8F-4BEF-BB74-131E36EA51A1 Q33567318-61C25F39-74CF-443F-B5BE-628FC57F96A9 Q33722806-5D614F67-3FA3-4C99-8C76-203F68888BF7 Q33812503-94C9D157-752B-4E17-B988-C7A72532A0BC Q33815625-F4D5B646-E133-4DAF-A140-9CE3A5C59888 Q33828091-E76B492C-ADCB-4A31-9E21-FAB8DADAADDB Q33921392-6DDC1FEC-54EA-48A2-8BE0-14B4AFEB007C Q33936642-E5124514-9491-4E25-B62A-37C70ABB55C7 Q34035340-3A8D0391-90CD-444A-AB99-5E99585240A3 Q34149341-61C7EAE7-3D02-4E80-AECA-C8A9A8CA4902 Q34313761-40238E82-7049-4DF8-B08A-128FD98CBD46 Q34452078-D6649624-7E5E-44C5-88F8-2B3CBABDDDEB Q34498562-BE073CA1-B8B9-4724-A066-A62F38972BE5 Q34544651-A5A5CF89-0CDF-42D6-9137-E65EE7D642CA Q34559786-5DCBE2DE-9A00-4C12-AEF2-BEB23D90C5ED Q34621519-546BE36D-87D2-486B-AE17-4442D7AAF783 Q34626034-63B50B57-78F1-4FFF-A94E-BB20A76FB18A Q34629075-FEE335E9-FF1D-4AC6-AACB-95B942552640 Q34772551-253092D5-20CA-4B94-A2D9-A92754EDFB2B Q34808553-CBFD02AB-9B1D-4BD6-AE68-5203304E87DF Q34921330-1E603F55-F42D-4B67-B68D-15E9CF8C2B94 Q35045900-56E7731A-6659-4FB1-BE1A-F92353DFF8BF Q35067758-251AFAC5-DB05-4CA4-85B0-7D2EBA662D26 Q35080447-31652D0E-F704-4D77-878A-ECF209111888 Q35220296-69792348-60E1-4447-9FFD-EC82A78FE20E

P2860

Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth

http://www.wikidata.org/entity/Q37202183

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2000

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Deactivation of peroxisome pro ...... ng cardiac hypertrophic growth

@en

Deactivation of peroxisome pro ...... g cardiac hypertrophic growth.

@nl

type

label

Deactivation of peroxisome pro ...... ng cardiac hypertrophic growth

@en

Deactivation of peroxisome pro ...... g cardiac hypertrophic growth.

@nl

prefLabel

Deactivation of peroxisome pro ...... ng cardiac hypertrophic growth

@en

Deactivation of peroxisome pro ...... g cardiac hypertrophic growth.

@nl

P1433

Q37202183-EF7A47E0-919E-444C-8370-F05375A3FA69

P1476

Q37202183-96848640-92F4-404C-BE4C-ED4ED5A68C2D

P2093

Q37202183-16A4CC18-C9F3-4CD3-8875-CFD8416D376C

Q37202183-3F5B07FF-1CA8-474A-890E-A3CC3E47394F

Q37202183-C6114475-D2D6-4B6E-82BD-C2AEC7860946

Q37202183-CD26725E-BF56-4D2F-9097-89BE35293E1C

Q37202183-D49C4269-2C2C-44BA-87B2-F70E3DB1B944

P2860

Q37202183-0192A2CE-970A-4C8E-8017-23ABD7623AC8

Q37202183-08F313B3-6A0C-4EFC-B868-C1A0DA2D90F0

Q37202183-0EBE4212-B195-4535-A6F8-5028399C35E3

Q37202183-1E8BB86E-D255-4DAD-BF9B-5CB0F8E72B7C

Q37202183-201B554E-1874-4E5F-9876-F0F0B0D66A52

Q37202183-30476225-A180-4990-A476-9DDC531160E8

Q37202183-360ECE67-FF61-4A93-B2C7-084BE3C5F1B3

Q37202183-434E83E7-D537-4A49-B44E-1D59BB5269C1

Q37202183-4F3C6E88-6296-4B2A-8BF9-F8E14142D700

Q37202183-5350465A-DFA4-4E41-A857-354C5221184F

P304

Q37202183-53D7D489-D16F-49BE-AAC1-74D3DE15D8EA

P31

Q37202183-37F94E3E-E01E-48DF-B05A-7A56F73CA635

P356

Q37202183-DA93329D-EBAB-4339-AFC7-B0B05E6C0160

P407

Q37202183-21BC5D1D-8C5F-49F0-89CA-2A495C5A643C

P433

Q37202183-7700D31E-DB3E-4460-A674-275653069EC0

P478

Q37202183-3CAC3DF6-4F36-4288-A008-E661E1F5605A

P577

Q37202183-9846E411-5EC5-4072-B572-5FA0233A31C1

P5875

Q37202183-825059AC-77E7-4767-9F74-8C39F4C8363A

P698

Q37202183-9AB57AEE-B505-486D-A670-C765CD12474F

P932

Q37202183-67BFD9EB-29A4-4655-A5E8-7706EB3EC93F

P356

P1433

Journal of Clinical Investigation

P1476

Deactivation of peroxisome pro ...... ng cardiac hypertrophic growth

@en

P2093

C J Weinheimer

http://www.w3.org/2001/XMLSchema#string

D P Kelly

http://www.w3.org/2001/XMLSchema#string

J M Brandt

http://www.w3.org/2001/XMLSchema#string

P M Barger

http://www.w3.org/2001/XMLSchema#string

T C Leone

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase Ibeta gene promoters by fatty acid enzyme substrate.

Signaling in myocardial hypertrophy: life after calcineurin?

Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases.

P304

1723-1730

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI9056

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2000-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12455586

http://www.w3.org/2001/XMLSchema#string

P698

10862787

http://www.w3.org/2001/XMLSchema#string

P932

378509

http://www.w3.org/2001/XMLSchema#string